Mizuho Oracle · ORCL

Mizuho Reiterates Outperform Rating on Oracle (June 3)

1 min read Reproduced verbatim
Rating
Outperform
Unchanged
Target
$320
from $400 (−20%)
Upside
+178%
ORCL at $115 today
Mizuho and Oracle logos

What the analyst said

Mizuho analyst Siti Panigrahi reiterated an Outperform rating and $320.00 price target on Oracle (NYSE: ORCL).

“We expect solid FQ4 results (on 6/10) and believe the setup is favorable as investor concerns have shifted from demand to execution.

FQ3 validated accelerating OCI conversion of $553B RPO, and FY27 revenue visibility. Beyond FQ4 revenue/EPS beat, FQ4 is a major catalyst.

Oracle has the opportunity to reframe debates around revenue acceleration (34% in FY27 from 17% in FY26), DC execution, BYOC/prepay economics, EPS leverage from restructuring, and funding/FCF visibility.

Importantly, FQ4 should materially reduce the primary overhang on the stock.

Initial FY27 CapEx guide should give investors a framework to triangulate forward CapEx against incremental AI revenue and confidence that total financing needs remain below $100B.

LT, we remain materially ahead of consensus on Oracle’s margin and FCF trajectory.

FCF inflects to positive $4B in our FY29E and $36B in FY30E, marking the point when Oracle self-funds growth and financing concerns weighing on sentiment should fade. Reiterate Outperform.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $115. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $320 target is 38% above the median.

Since the note ORCL has moved −53% (from $245). 12-month window: day 155 of 365, closes on June 3, 2027.

Track record

This callOpen: ORCL has not reached $320 yet. This 12-month target is scored on June 3, 2027.

Firm track recordMizuho: 88% of its 69 targets at least a year old were reached within 12 months (#2 of 26 firms). Accuracy ranking →

Mizuho on Oracle

Mizuho price targets on Oracle

8 calls from March 11, 2026 to July 21, 2026. The target went from $400 to $320 (−20%). The rating stayed Buy.

Mizuho targetORCL share price
  1. July 21, 2026Kept the $320 targetBuy$320
  2. June 15, 2026Kept the $320 targetBuy$320
  3. June 11, 2026Kept the $320 targetBuy$320
  4. June 3, 2026 This noteTarget cut from $400 (−20%)Buy$320
  5. April 10, 2026Target raised from $320 (+25%)Buy$400
  6. April 7, 2026Kept the $320 targetBuy$320
  7. March 16, 2026Target cut from $400 (−20%)Buy$320
  8. March 11, 2026Earliest call shownBuy$400
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.